Skip to main content
Log in

Failure to measure plasma activated factor XIII during disseminated intravascular coagulation

  • Original Contributions
  • Published:
Ricerca in clinica e in laboratorio

Summary

The search for activated products of coagulation factors in blood is of considerable clinical interest because its detection would indicate activation of the clotting system. Factor XIII circulates as inactive zymogen and becomes enzymatically active after thrombin or factor Xa activation. Employing an amine-incorporating system, activated factor XIII was measured in normal and pathological plasma from leukemic patients with overt laboratory signs of disseminated intravascular coagulation (DIC). Only traces of the activated factor were detected in both normal and DIC plasma. The method, sensitive and specific, as shown by the results of measurements on the plasma of 8 patients with congenital deficiency and on normal serum, did not prove to be useful for detecting pathologicalin vivo thrombin generation.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Barbui T., Rodeghiero F., Dini E., Mariani G., Papa M. L., De Biasi R., Cordero Murillo R., Montero Umana C.: Subunit A and S inheritance in foud families with congenital factor XIII deficiency — Brit. J. Haemat.38, 267, 1978.

    Article  PubMed  CAS  Google Scholar 

  2. Chung S. I.: Comparative studies on tissue transglutaminase and factor XIII — Ann. N.Y. Acad. Sci.202, 240, 1972.

    Article  PubMed  CAS  Google Scholar 

  3. Lorand L., Konishi K.: Activation of the fibrin stabilizing factor of plasma by thrombin — Arch. Biochem.105, 58, 1964.

    Article  PubMed  CAS  Google Scholar 

  4. Lorand L., Urayama T., De Kiewiet J. W. T., Nossel H. L.: Diagnostic and genetic studies on fibrin stabilizing factor with a new assay based on amine incorporation — J. clin. Invest.48, 1054, 1969.

    Article  PubMed  CAS  Google Scholar 

  5. McDonagh J., McDonagh R. P.: Alternative pathways for activation of factor XIII — Brit. J. Haemat.30, 465, 1975.

    Article  PubMed  CAS  Google Scholar 

  6. Nelson J. C., Lerner L. G.: Detection of factor XIIIa (active fibrin stabilizing factor) in normal plasma — Blood52, 581, 1978.

    PubMed  CAS  Google Scholar 

  7. Rodeghiero F., Barbui T.: Fibrin cross-linking in congenital factor XIII deficiency — J. clin. Path.33, 434, 1980.

    Article  PubMed  CAS  Google Scholar 

  8. Rodeghiero F., Barbui T., Battista R., Chisesi T., Rigoni G., Dini E.: Molecular subunits and transamidase activity of factor XIII during disseminated intravascular coagulation in acute leukaemia — Thrombos. Haemost.43, 6, 1980.

    CAS  Google Scholar 

  9. Rodeghiero F., Barbui T., Dal Belin A.: Simplified method for the polyacrylamide gel electrophoresis of fibrin — G. Arterioscler. (New series)2, 23, 1977.

    CAS  Google Scholar 

  10. Sixma J. J.: The prethrombotic state — Brit. J. Haemat.46, 515, 1980.

    Article  PubMed  CAS  Google Scholar 

  11. Triantaphyllopoulos D. C.: The inactivation of factor XIII during blood coagulation — Thrombos. Res.3, 241, 1973.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Rodeghiero, F., Morbin, M. & Barbui, T. Failure to measure plasma activated factor XIII during disseminated intravascular coagulation. La Ricerca Clin. Lab. 11, 333–336 (1981). https://doi.org/10.1007/BF02909031

Download citation

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02909031

Key-words

Navigation